Related Experiment Video

Updated: Apr 18, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

34.3K

Pseudomonas aeruginosa: evolution of antimicrobial resistance and implications for therapy

Kate McCarthy1

  • 1University of Queensland, UQ Centre for Clinical Research, Brisbane, Australia.

Seminars in Respiratory and Critical Care Medicine
|February 3, 2015
PubMed

Insights

Pseudomonas aeruginosa is a dangerous pathogen causing healthcare infections. Rising multidrug resistance in this adaptable bacteria limits treatment options, highlighting a global health emergency.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is a significant opportunistic pathogen.
  • It causes severe healthcare-associated infections, including bloodstream infections and ventilator-associated pneumonia.
  • This bacterium exhibits remarkable adaptability to various environments and host colonization.

Purpose of the Study:

  • To highlight the growing threat of Pseudomonas aeruginosa infections.
  • To emphasize the escalating problem of antimicrobial resistance in this pathogen.
  • To underscore the urgent need for novel therapeutic strategies.

Main Methods:

  • Review of epidemiological data on healthcare-associated infections.
  • Analysis of trends in antimicrobial resistance, including multidrug and pan-drug resistance.
  • Examination of current and emerging treatment modalities.

Main Results:

  • In 2011, Pseudomonas aeruginosa accounted for 7.1% of US healthcare-associated infections.
  • Significant morbidity and mortality are associated with P. aeruginosa bloodstream infections and VAP.
  • Global spread of multidrug-resistant and pan-drug-resistant strains has been observed.
  • Limited antibiotic treatment options are available due to widespread resistance.

Conclusions:

  • Pseudomonas aeruginosa poses a critical threat in healthcare settings.
  • The rise of multidrug resistance in P. aeruginosa is a global health emergency.
  • Innovative treatment approaches, including combination and inhalational therapies, are essential.

More Related Videos

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants11:35

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

8.7K
Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model07:39

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

Published on: April 6, 2021

4.4K

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
155
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
60
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
926
Antibiotic Selection00:57

Antibiotic Selection

Overview
62.4K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
750